{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/headache-cluster/management/management/","result":{"pageContext":{"chapter":{"id":"d58dee4b-524d-5c05-ab56-a3f2e8267015","slug":"management","fullItemName":"Scenario: Management","depth":2,"htmlHeader":"<!-- begin field d7f31ea7-49e5-425f-add4-172ce66a5c21 --><h2>Scenario: Management of cluster headache</h2><!-- end field d7f31ea7-49e5-425f-add4-172ce66a5c21 -->","summary":"Covers the primary care management of people with cluster headache or suspected cluster headache.","htmlStringContent":"<!-- begin item d88c9aca-e40d-4316-b5b7-b2e198c53b77 --><!-- begin field c3b36a28-b968-4789-b368-acbd0085c50d --><p>From age 16 years onwards.</p><!-- end field c3b36a28-b968-4789-b368-acbd0085c50d --><!-- end item d88c9aca-e40d-4316-b5b7-b2e198c53b77 -->","topic":{"id":"d4372db3-c286-5b08-ae88-4b378cc26f85","topicId":"1780a283-d8d8-4a78-9869-4aa0bcb926e5","topicName":"Headache - cluster","slug":"headache-cluster","lastRevised":"Last revised in November 2017","chapters":[{"id":"dded59b4-b26d-58ac-b4b5-22a36bbce96f","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"fb41d21e-afee-5c8f-9fe3-7e5d7273f990","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"f42da194-bfee-5d0c-9cd9-fe2352e484d8","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"603364e1-1e74-5796-9f29-7f6f277d42f3","slug":"changes","fullItemName":"Changes"},{"id":"49b37f22-5d81-55cd-9f09-2c42bfe7a440","slug":"update","fullItemName":"Update"}]},{"id":"fb7884e6-910a-5be8-b49b-4d0d9901e5bb","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"e4d8ae70-7df4-595f-b078-15b0686480bc","slug":"goals","fullItemName":"Goals"},{"id":"e06fcd82-7749-5fc4-99a5-a659ad138d75","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"b2ce29d8-0327-5dc3-b537-4eb0d84ff0df","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"911f8cac-31a2-54f6-8084-565c4516e965","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"45526ba7-7e5c-5e4d-aea2-c6c4785109c9","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"204fce42-b598-5c01-b2f8-dc34334f94ef","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"d652875d-acbb-5f7e-9327-464a8d24509d","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"2513432e-c9c8-5a4a-b045-88b3c9db1c5f","slug":"definition","fullItemName":"Definition"},{"id":"f6b0ddc0-0058-5caa-a90e-fde4e7016138","slug":"cause","fullItemName":"Cause"},{"id":"24bb1ef8-f348-5f38-9375-b0ffcc04fe19","slug":"prevalence","fullItemName":"Prevalence"},{"id":"ad96cb6b-adfd-5eef-ac92-e130eebc9a8d","slug":"prognosis","fullItemName":"Prognosis"},{"id":"09b005ad-76ed-5ffb-9cf8-f7f5fdc3d524","slug":"complications","fullItemName":"Complications"}]},{"id":"eb2c501e-d43f-5455-b294-8c75e0b43b4f","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"99fb5731-772f-5d15-92ac-3e0d36235be9","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"dd1bbca4-1759-5853-a0b4-d6c95f1b4e22","slug":"assessment","fullItemName":"Assessment"},{"id":"270554de-33be-56a1-9ab5-db4bc1d5bfeb","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"4952c884-725e-51f7-bde4-95e2418f6d18","fullItemName":"Management","slug":"management","subChapters":[{"id":"d58dee4b-524d-5c05-ab56-a3f2e8267015","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"5dbc1f0e-638e-542a-bfb4-76477f824f0b","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"bbfa7c46-4e1f-5d21-a8cb-de6d17b9dd04","slug":"sumatriptan-zolmitriptan","fullItemName":"Sumatriptan and zolmitriptan"}]},{"id":"49f18d8e-055b-5a9d-8737-d359c87ff9ae","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"ae4fda2b-dde5-5641-aa58-5c38a3417e57","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"1278ee56-1831-5a74-b634-e5de752cb567","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"11a5b228-ed75-5a88-aaef-1055082e8cfe","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"88f71638-0d83-5cc8-9189-6a8cb83aede0","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"04c06162-a368-59ad-b092-c583527f05a3","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"e2804080-7722-535f-84d1-3394e9874c9a","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"8b309d7e-58c0-5822-90e8-eb5941b856db","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"4952c884-725e-51f7-bde4-95e2418f6d18","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"0ebf0a8b-7cb7-5ddf-b206-b5ad4263d395","slug":"managing-suspected-cluster-headache","fullItemName":"Managing suspected cluster headache","depth":3,"htmlHeader":"<!-- begin field 4291f3e3-5cf4-44ec-9165-c4cb3bf6cfd5 --><h3>How should I manage someone with suspected cluster headache?</h3><!-- end field 4291f3e3-5cf4-44ec-9165-c4cb3bf6cfd5 -->","summary":null,"htmlStringContent":"<!-- begin item 870855f2-5cac-432f-a7bf-79db4ab9afca --><!-- begin field 3311c339-7b1a-4962-ac64-37a99628192f --><ul><li><strong>If the person has any red flags for a serious <a class=\"topic-reference internal-reference\" href=\"/topics/headache-cluster/diagnosis/differential-diagnosis/\">secondary cause of headache</a>:</strong><ul><li>Refer to secondary care (with urgency depending on the clinical situation).</li><li>For information on red flags see the section on <a class=\"topic-reference external-reference\" href=\"/topics/headache-assessment/diagnosis/headache-diagnosis/#red-flags\">warning features of serious causes of headache</a> in the CKS topic <a class=\"topic-reference external-reference\" href=\"/topics/headache-assessment/\">Headache - assessment</a>.</li></ul></li><li><strong>If clinical features are consistent with cluster headache refer to/discuss with a neurologist or GP with a special interest in headache all:</strong><ul><li>People presenting with a first bout of cluster headache — confirmation of diagnosis by a specialist is required and may involve neuroimaging. Preventative treatment (such as verapamil) may be considered.</li><li>People with confirmed cluster headache who have developed new symptoms or signs suggestive of a serious underlying secondary cause.</li><li>Pregnant or breastfeeding women — all pregnant women with cluster headache should be referred to a specialist in neurology.</li></ul></li><li><strong>Manage acute bouts of confirmed cluster headache:</strong><ul><li><strong>If appropriate, offer a subcutaneous or nasal triptan to people aged over 18 years — options include:</strong><ul><li>Sumatriptan by subcutaneous injection (for adult) — initially 6 mg for 1 dose, followed by 6 mg after at least 1 hour if headache recurs (people not responding to the initial dose should <em>not</em> take a second dose for the same attack); maximum 12 mg per day <strong><em>or</em></strong></li><li>Sumatriptan by intranasal administration (for adult aged 18–65 years) — initially 10–20 mg, dose to be administered into one nostril, followed by 10–20 mg after at least 2 hours only if the headache recurs (people not responding to the initial dose should <em>not</em> take a second dose for the same attack); maximum 40 mg per day <strong><em>or</em></strong></li><li>Zolmitriptan by intranasal administration (unlicensed indication, for adult) — 5 mg dose to be administered as soon as possible after onset into one nostril only, followed by 5 mg after at least 2 hours only if symptoms recur; maximum 10 mg per day.</li><li>For further information, including contraindications, see the <a class=\"topic-reference external-reference\" href=\"/topics/migraine/prescribing-information/\">Prescribing section</a> in the CKS topic <a class=\"topic-reference external-reference\" href=\"/topics/migraine/\">Migraine</a>.</li></ul></li><li><strong>Do not offer </strong>paracetamol, nonsteroidal anti-inflammatories, opioids, ergots or oral triptans for the acute treatment of cluster headache.</li><li><strong>Offer short burst oxygen therapy</strong><ul><li>If not contra-indicated, provide 100% oxygen at a flow rate of 12–15 litres per minute via a non-rebreather face mask for 15 to 20 minutes.</li><li>Home oxygen can be provided through the Home Oxygen Order Form (HOOF).</li></ul></li><li><strong>Advise the person on avoidance of triggers:</strong><ul><li>Cluster attacks may be triggered or exacerbated by behaviours such as alcohol consumption and smoking.</li><li>For further information, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/alcohol-problem-drinking/\">Alcohol - problem drinking</a> and <a class=\"topic-reference external-reference\" href=\"/topics/smoking-cessation/\">Smoking cessation</a>.</li></ul></li><li><strong>Advise the person on the risk of medication overuse headache</strong><ul><li>People with chronic cluster headache may overuse symptomatic medications to treat attacks and develop medication overuse headache.</li><li>A headache diary recording frequency, severity, duration and characteristics of attacks can help differentiate between headache types.</li><li>For further information, see the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/headache-medication-overuse/\">Headache - medication overuse</a>.</li></ul></li><li><strong>Identify and manage comorbidities</strong><ul><li>Several conditions including depression, anxiety, and sleep apnoea may co-exist with cluster headache — ensure that co-morbidities are adequately treated. For further information, see the CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/depression/\">Depression</a>, <a class=\"topic-reference external-reference\" href=\"/topics/generalized-anxiety-disorder/\">Generalized anxiety disorder</a> and <a class=\"topic-reference external-reference\" href=\"/topics/obstructive-sleep-apnoea-syndrome/\">Obstructive sleep apnoea syndrome</a>.</li></ul></li><li><strong>Provide written and oral patient information on cluster headache and support organizations:</strong><ul><li>Patient information on <a href=\"https://www.nhs.uk/conditions/cluster-headaches/\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"2cbfa3e1-76a6-49b9-b3d1-a98d002b6c47\">Cluster Headache</a> is available on the <a href=\"https://www.nhs.uk/pages/home.aspx\" target=\"_blank\" rel=\"noopener\" data-hyperlink-id=\"ce9d0a06-3fe6-4a96-8946-a98d002b6c5d\">NHS </a><a href=\"https://www.nhs.uk/conditions/\" data-hyperlink-id=\"d8fcb2f7-c2c7-46de-b5b4-aa560092ae9e\">A-Z</a> website.</li></ul></li><li><strong>If uncertain about diagnosis/management or first line measures in primary care fail</strong> – discuss with a specialist in neurology.</li></ul></li></ul><!-- end field 3311c339-7b1a-4962-ac64-37a99628192f --><!-- end item 870855f2-5cac-432f-a7bf-79db4ab9afca -->","subChapters":[{"id":"2562ef20-d6e6-5f8e-9e82-a1125f409883","slug":"basis-for-recommendation-16b","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field 3ea1666a-6189-45ae-8d89-99e0a236cc74 --><h4>Basis for recommendation</h4><!-- end field 3ea1666a-6189-45ae-8d89-99e0a236cc74 -->","summary":null,"htmlStringContent":"<!-- begin item 16b34dbc-998f-4c46-9515-17312818fef4 --><!-- begin field 4cd00501-fd74-452d-8db0-3987c1de3e7c --><p>The recommendations on management of cluster headache are based on clinical guidelines <em>Guidelines for All Healthcare Professionals in the Diagnosis and Management of Migraine, Tension-Type, Cluster and Medication-Overuse Headache</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-cluster/references/\">BASH, 2010</a>], <em>Headaches in over 12s: diagnosis and management (updated November 2015)</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-cluster/references/\">NICE, 2012</a>], <em>The International Classification of Headache Disorders, 3rd edition (beta version)</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-cluster/references/\">IHS, 2013</a>], <em>Diagnosis and treatment of headache</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-cluster/references/\">ICSI, 2013</a>],  <em>British Thoracic Society guidelines for home oxygen use in adults: accredited by NICE</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-cluster/references/\">Hardinge, 2015</a>], <em>Guideline for primary care management of headache in adults</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-cluster/references/\">Becker, 2015</a>],  and the <em>European Headache Federation consensus on technical investigation for primary headache disorders</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-cluster/references/\">Mitsikostas, 2015</a>] and expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-cluster/references/\">Miller, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-cluster/references/\">Obermann, 2015</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-cluster/references/\">Weaver-Agostoni, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-cluster/references/\">Hale, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-cluster/references/\">Robbins, 2016</a>].</p><h5>Referral to secondary care</h5><ul><li>The National Institute of Care and Health Excellence (NICE) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-cluster/references/\">NICE, 2012</a>] recommends:<ul><li>Consideration of neuroimaging and specialist assessment in people presenting with a first bout of cluster headache.</li><li>Referral of all pregnant women with cluster headache to neurology.</li></ul></li><li>The British Association for the Study of Headache (BASH) recommend management of cluster headache by specialists who see the disorder frequently [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-cluster/references/\">BASH, 2010</a>]. </li></ul><h5>Acute treatment of confirmed cluster headache</h5><ul><li>Evidence based treatments for relief of individual cluster attacks include subcutaneous or nasal triptans and oxygen — there is no evidence to support the use of opioids, nonsteroidal anti-inflammatories, paracetamol or oral triptans [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-cluster/references/\">NICE, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-cluster/references/\">Miller, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-cluster/references/\">Weaver-Agostoni, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-cluster/references/\">Becker, 2015</a>].</li><li>NICE and BASH recommend that adults with acute attacks of cluster headache are offered oxygen and/or a subcutaneous or nasal triptan [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-cluster/references/\">BASH, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-cluster/references/\">NICE, 2012</a>].<ul><li><strong>Triptans</strong><ul><li>The information on dosage of triptans is taken from the British National Formulary — licenced indications and contraindications vary between products [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-cluster/references/\">BNF 73, 2017</a>].</li><li>A Cochrane review (n = 6 studies) concluded from limited data that subcutaneous sumatriptan 6 mg was superior to intranasal zolmitriptan 5 mg or 10 mg for rapid (15 minute) relief of pain due to cluster headache. Oral triptans were not considered appropriate [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-cluster/references/\">Law, 2013</a>].</li><li>BASH recommend sumatriptan 6mg subcutaneously as the treatment of choice, unless contraindicated [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-cluster/references/\">BASH, 2010</a>].</li></ul></li><li><strong>Oxygen</strong><ul><li>NICE and the British Thoracic Society (BTS) recommend treatment of acute cluster headache with 100% oxygen at a flow rate of at least 12 litres per minute through a non-rebreathing mask and a reservoir bag [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-cluster/references/\">NICE, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-cluster/references/\">Hardinge, 2015</a>].</li><li>NICE also recommend that provision of home and ambulatory oxygen should be arranged — the BTS Home Oxygen Guideline provides detailed evidence-based guidance for the use of home oxygen for patients out of hospital including people with cluster headache [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-cluster/references/\">Hardinge, 2015</a>].</li></ul></li></ul></li></ul><h5>Patient education</h5><ul><li>The NICE clinical guideline [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-cluster/references/\">NICE, 2012</a>] recommends that all people with headache be provided with written and oral patient information on cluster headache and support organizations.<ul><li>Expert opinion in review articles is that patient education is important, and should include discussion on managing or avoiding triggers such as smoking, alcohol and volatile substances [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-cluster/references/\">Miller, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-cluster/references/\">Weaver-Agostoni, 2013</a>].</li></ul></li></ul><!-- end field 4cd00501-fd74-452d-8db0-3987c1de3e7c --><!-- end item 16b34dbc-998f-4c46-9515-17312818fef4 -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}